Benjamin Graham fit · Defensive deep-value investing
Is West Pharmaceutical Services, Inc. (WST) a Benjamin Graham Stock?
Meets 4/7 Graham criteria - classic deep-value candidate.
88/100
ALikely Graham stock
4/7 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 80 → lifted to 88 before grade derivation.
Benjamin Graham's Criteria, Applied to WST
P/E ≤ 15
key39.8x
P/B ≤ 1.5
key7.2x
Current ratio ≥ 2
2.7x
Debt / Equity ≤ 1
0.1x
5y profitable
keyYes
Earnings yield ≥ 7%
2.5%
Revenue growing
2.1%
How WST Scores on Other Strategies
Live Financial Snapshot
Market cap
$22.35B
P/E (TTM)
39.8x
ROIC (TTM)
15.24%
Gross margin
36.24%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is WST's Benjamin Graham fit score?
WST scores 88/100 on our Benjamin Graham fit engine - grade A. Meets 4/7 Graham criteria - classic deep-value candidate.
Does Benjamin Graham actually own WST?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends WST.
How often is this score updated?
WST's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends WST.